Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) EBT Margin (2019 - 2025)

Pulmonx (LUNG) has disclosed EBT Margin for 7 consecutive years, with 64.31% as the latest value for Q3 2025.

  • Quarterly EBT Margin rose 412.0% to 64.31% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 61.39% through Sep 2025, up 972.0% year-over-year, with the annual reading at 66.71% for FY2024, 2106.0% up from the prior year.
  • EBT Margin for Q3 2025 was 64.31% at Pulmonx, down from 62.85% in the prior quarter.
  • The five-year high for EBT Margin was 55.28% in Q4 2024, with the low at 146.14% in Q1 2022.
  • Average EBT Margin over 5 years is 88.06%, with a median of 84.0% recorded in 2023.
  • Peak annual rise in EBT Margin hit 21720bps in 2021, while the deepest fall reached -5252bps in 2021.
  • Over 5 years, EBT Margin stood at 93.77% in 2021, then grew by 3bps to 91.0% in 2022, then rose by 22bps to 70.75% in 2023, then rose by 22bps to 55.28% in 2024, then fell by -16bps to 64.31% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 64.31%, 62.85%, and 63.51% for Q3 2025, Q2 2025, and Q1 2025 respectively.